---
schema_version: "secwatch.filing_event.v1"
accession: "0001493152-25-028301"
form_type: "8-K"
ticker: "SYRA"
cik: "0001922335"
company_name: "Syra Health Corp"
filed_at: "2025-12-18T23:59:59+00:00"
generated_at: "2026-05-16T12:47:27.536701+00:00"
event_type: "leadership"
sentiment: "neutral"
materiality_score: 0.6
calibrated_materiality_score: 0.6
confidence: "high"
source: SEC EDGAR
---

# Syra Health appoints Gregory R. Alexander as CEO effective Jan 5, 2026

## Summary
- New CEO Gregory R. Alexander receives $251k base salary, 30% target bonus, and 110,537 RSUs.
- Also granted 257,920 stock options (Class B) and 368,458 performance stock units.
- Alexander previously served as SVP at Ellipsis Health, Chief Growth Officer at CitizensRx (tripled sales), and market leader at Lumeris (expanded from 3 to 11 markets).
- He will replace interim CEO Priya Prasad; appointment follows an extensive national search.
- Alexander is a former U.S. Marine Corps officer with over 20 years of P&L experience in healthcare.

## SEC filing metadata
- accession: 0001493152-25-028301
- form_type: 8-K
- ticker: SYRA
- cik: 0001922335
- company_name: Syra Health Corp
- filed_at: 2025-12-18T23:59:59+00:00
- event_type: leadership
- sentiment: neutral
- materiality_score: 0.6
- calibrated_materiality_score: 0.6
- confidence: high
- sec_items: 5.02, 8.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1922335/000149315225028301/0001493152-25-028301-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1922335/000149315225028301/form8-k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001493152-25-028301
- JSON: https://secwatch.observer/filing/0001493152-25-028301.json
- Plain text: https://secwatch.observer/filing/0001493152-25-028301.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.